From the Primary Care Research Group, Institute of Health Services Research (C.E.C., F.C.W., S.T.J.M., S.F.M., R.S.T., J.L.C.), University of Exeter Medical School, College of Medicine & Health, Devon, England.
Patient and Public Involvement Team, PenCLAHRC (K.B., J.G., N.R., M.T.), University of Exeter Medical School, College of Medicine & Health, Devon, England.
Hypertension. 2021 Feb;77(2):650-661. doi: 10.1161/HYPERTENSIONAHA.120.15997. Epub 2020 Dec 21.
Systolic interarm differences in blood pressure have been associated with all-cause mortality and cardiovascular disease. We undertook individual participant data meta-analyses to (1) quantify independent associations of systolic interarm difference with mortality and cardiovascular events; (2) develop and validate prognostic models incorporating interarm difference, and (3) determine whether interarm difference remains associated with risk after adjustment for common cardiovascular risk scores. We searched for studies recording bilateral blood pressure and outcomes, established agreements with collaborating authors, and created a single international dataset: the Inter-arm Blood Pressure Difference - Individual Participant Data (INTERPRESS-IPD) Collaboration. Data were merged from 24 studies (53 827 participants). Systolic interarm difference was associated with all-cause and cardiovascular mortality: continuous hazard ratios 1.05 (95% CI, 1.02-1.08) and 1.06 (95% CI, 1.02-1.11), respectively, per 5 mm Hg systolic interarm difference. Hazard ratios for all-cause mortality increased with interarm difference magnitude from a ≥5 mm Hg threshold (hazard ratio, 1.07 [95% CI, 1.01-1.14]). Systolic interarm differences per 5 mm Hg were associated with cardiovascular events in people without preexisting disease, after adjustment for Atherosclerotic Cardiovascular Disease (hazard ratio, 1.04 [95% CI, 1.00-1.08]), Framingham (hazard ratio, 1.04 [95% CI, 1.01-1.08]), or QRISK cardiovascular disease risk algorithm version 2 (QRISK2) (hazard ratio, 1.12 [95% CI, 1.06-1.18]) cardiovascular risk scores. Our findings confirm that systolic interarm difference is associated with increased all-cause mortality, cardiovascular mortality, and cardiovascular events. Blood pressure should be measured in both arms during cardiovascular assessment. A systolic interarm difference of 10 mm Hg is proposed as the upper limit of normal. Registration: URL: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42015031227.
收缩压臂间差异与全因死亡率和心血管疾病有关。我们进行了个体参与者数据荟萃分析,以(1)量化收缩压臂间差异与死亡率和心血管事件的独立关联;(2)制定和验证纳入臂间差异的预后模型,以及(3)确定臂间差异在调整常见心血管风险评分后是否仍与风险相关。我们搜索了记录双侧血压和结局的研究,与合作作者达成了协议,并创建了一个单一的国际数据集:臂间血压差异 - 个体参与者数据(INTERPRESS-IPD)合作。数据合并自 24 项研究(53827 名参与者)。收缩压臂间差异与全因和心血管死亡率相关:每 5 毫米汞柱收缩压臂间差异连续危险比分别为 1.05(95%可信区间,1.02-1.08)和 1.06(95%可信区间,1.02-1.11)。全因死亡率的危险比随着臂间差异幅度从≥5 毫米汞柱阈值增加(危险比,1.07[95%可信区间,1.01-1.14])。在调整动脉粥样硬化性心血管疾病(危险比,1.04[95%可信区间,1.00-1.08])、弗雷明汉(危险比,1.04[95%可信区间,1.01-1.08])或 QRISK 心血管疾病风险算法 2 版(QRISK2)(危险比,1.12[95%可信区间,1.06-1.18])心血管风险评分后,每 5 毫米汞柱收缩压臂间差异与无预先存在疾病的人发生心血管事件相关。我们的研究结果证实,收缩压臂间差异与全因死亡率、心血管死亡率和心血管事件增加相关。在心血管评估期间,应测量双臂血压。建议将 10 毫米汞柱的收缩压臂间差异作为正常上限。注册:网址:https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42015031227。